Company intelligence / Profile preview
Astel Medica
- Ownership
- Private
- Employees
- ~32
- Development stage
- Other
Overview
Astel Medica is a Belgian pharmaceutical company specializing in the development and manufacturing of innovative, evidence-based symbiotics and probiotics. The company collaborates with several universities to advance research and provide high-quality probiotic products for various therapeutic areas including gynecology, immunology, pediatrics, and cardiology. It has over 20 years of experience in live bacteria-based products.
- Therapeutic areas
- ImmunologyCardiovascularWomen's HealthOther
- Modalities
- ProbioticsLive biotherapeutic product therapySmall molecule
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Astel Medica.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Astel Medica.